Xavier Saelens
#56,261
Most Influential Person Now
Belgian scientist
Xavier Saelens's AcademicInfluence.com Rankings
Xavier Saelensbiology Degrees
Biology
#2781
World Rank
#4365
Historical Rank
Biotechnology
#56
World Rank
#57
Historical Rank
Virology
#120
World Rank
#124
Historical Rank
Molecular Biology
#1063
World Rank
#1087
Historical Rank
Download Badge
Biology
Xavier Saelens's Degrees
- PhD Biotechnology Ghent University
- Masters Biochemistry Ghent University
- Bachelors Biology Ghent University
Similar Degrees You Can Earn
Why Is Xavier Saelens Influential?
(Suggest an Edit or Addition)According to Wikipedia, Xavier Saelens is a Belgian scientist and currently his main research interest is finding a universal influenza vaccine. He is a lecturer in Virology and Group Leader of the Molecular Virology Unit at the University of Ghent .
Xavier Saelens's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Toxic proteins released from mitochondria in cell death (2004) (973)
- A universal influenza A vaccine based on the extracellular domain of the M2 protein (1999) (741)
- The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet (2002) (612)
- Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies (2020) (443)
- Mitochondrial intermembrane proteins in cell death. (2003) (406)
- Alice in caspase land. A phylogenetic analysis of caspases from worm to man (2002) (369)
- M2e-based universal influenza A vaccine. (2009) (276)
- Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection (2011) (269)
- Mx Proteins: Antiviral Gatekeepers That Restrain the Uninvited (2013) (225)
- Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments (2009) (205)
- Interferon-Inducible Protein Mx1 Inhibits Influenza Virus by Interfering with Functional Viral Ribonucleoprotein Complex Assembly (2012) (174)
- STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters (2020) (173)
- Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules (2011) (157)
- Translation Inhibition in Apoptosis (2001) (157)
- Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA (2002) (155)
- Caspase-1 Activates Nuclear Factor of the κ-Enhancer in B Cells Independently of Its Enzymatic Activity* (2004) (140)
- An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2* (2008) (138)
- Nanobodies®: new ammunition to battle viruses. (2011) (134)
- CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine. (2008) (132)
- The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection. (2006) (127)
- Differential Signaling to Apoptotic and Necrotic Cell Death by Fas-associated Death Domain Protein FADD* (2004) (126)
- Improved design and intranasal delivery of an M2e-based human influenza A vaccine. (2006) (125)
- M2e-Based Universal Influenza A Vaccines (2015) (125)
- Proteome-wide Identification of HtrA2/Omi Substrates. (2007) (124)
- Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state (2017) (123)
- Correction for Phagocytosis of Necrotic Cells by Macrophages Is Phosphatidylserine Dependent and Does Not Induce Inflammatory Cytokine Production (2003) (114)
- Polymeric multilayer capsule-mediated vaccination induces protective immunity against cancer and viral infection. (2012) (113)
- Bcl-2 Family Members as Sentinels of Cellular Integrity and Role of Mitochondrial Intermembrane Space Proteins in Apoptotic Cell Death (2003) (107)
- Necrosis is associated with IL-6 production but apoptosis is not. (2006) (104)
- Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies. (2008) (104)
- INCA, a Novel Human Caspase Recruitment Domain Protein That Inhibits Interleukin-1β Generation* (2004) (98)
- Butylated hydroxyanisole is more than a reactive oxygen species scavenger (2006) (94)
- Translation inhibition in apoptosis: caspase-dependent PKR activation and eIF2-alpha phosphorylation. (2001) (92)
- Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection. (2011) (89)
- M2-based influenza vaccines: recent advances and clinical potential (2017) (88)
- Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes (2018) (86)
- Developing 3D SEM in a broad biological context (2015) (86)
- Challenges and advances towards the rational design of mRNA vaccines. (2013) (82)
- Caspases are not localized in mitochondria during life or death (2002) (81)
- Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration. (2017) (81)
- Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses. (2016) (80)
- Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase. (1997) (80)
- Use of HDEL‐tagged Trichoderma reesei mannosyl oligosaccharide 1,2‐α‐D‐mannosidase for N‐glycan engineering in Pichia pastoris (2001) (80)
- The Sin3a repressor complex is a master regulator of STAT transcriptional activity (2012) (80)
- Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing (2015) (79)
- Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection* (2012) (79)
- A20 (Tnfaip3) Deficiency in Myeloid Cells Protects against Influenza A Virus Infection (2012) (77)
- Protein synthesis persists during necrotic cell death (2005) (74)
- Immunization with M2e-Displaying T7 Bacteriophage Nanoparticles Protects against Influenza A Virus Challenge (2012) (74)
- A Novel Caspase-2 Complex Containing TRAF2 and RIP1* (2005) (73)
- Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies (2020) (69)
- M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection (2017) (66)
- Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin. (1999) (63)
- Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine. (2009) (63)
- Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies (2017) (62)
- The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections (2011) (59)
- Optineurin deficiency in mice is associated with increased sensitivity to Salmonella but does not affect proinflammatory NF‐κB signaling (2016) (58)
- Single-Domain Antibodies and Their Formatting to Combat Viral Infections (2018) (58)
- Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state (2017) (57)
- Single-Domain Antibodies Targeting Neuraminidase Protect against an H5N1 Influenza Virus Challenge (2014) (55)
- Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion. (2011) (55)
- Hepatitis B core–based virus–like particles to present heterologous epitopes (2013) (55)
- Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages* (2016) (52)
- A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus. (2011) (50)
- Structure of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus in Complex with a Protective Monoclonal Antibody (2015) (50)
- Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein (2014) (49)
- Natural and long-lasting cellular immune responses against influenza in the M2e-immune host (2012) (47)
- Pandemic preparedness: toward a universal influenza vaccine. (2009) (45)
- Erratum: Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies (Cell (2020) 181(5) (1004–1015.e15), (S0092867420304943), (10.1016/j.cell.2020.04.031)) (2020) (45)
- STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters (2020) (45)
- A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection (2016) (44)
- Influenza vaccines: T-cell responses deserve more attention (2012) (44)
- Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies (2016) (44)
- Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice (2013) (43)
- Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy. (2018) (43)
- Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist. (2018) (42)
- M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A (2013) (42)
- Proteolysis of Enteric Cell Villin by Entamoeba histolytica Cysteine Proteinases* (2003) (41)
- The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines (2019) (40)
- Clinical Potential of Prefusion RSV F-specific Antibodies. (2017) (40)
- Akt Inhibitor MK2206 Prevents Influenza pH1N1 Virus Infection In Vitro (2014) (37)
- Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses (2019) (37)
- Vaccine options for influenza: thinking small. (2018) (37)
- Assessment of the Antiviral Properties of Recombinant Porcine SP-D against Various Influenza A Viruses In Vitro (2011) (36)
- Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages (2015) (36)
- In vitro conversion of the carbohydrate moiety of fungal glycoproteins to mammalian-type oligosaccharides--evidence for N-acetylglucosaminyltransferase-I-accepting glycans from Trichoderma reesei. (1997) (36)
- A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study (2018) (34)
- Intracellular Delivery of mRNA in Adherent and Suspension Cells by Vapor Nanobubble Photoporation (2020) (33)
- Next-Generation Sequencing: An Eye-Opener for the Surveillance of Antiviral Resistance in Influenza. (2019) (32)
- The caspase family (2003) (32)
- Regulation of kynurenine biosynthesis during influenza virus infection (2017) (32)
- Apoptosis of hematopoietic cells induced by growth factor withdrawal is associated with caspase-9 mediated cleavage of Raf-1 (2005) (32)
- Recombinant Influenza Virus Carrying the Respiratory Syncytial Virus (RSV) F85-93 CTL Epitope Reduces RSV Replication in Mice (2013) (32)
- The mitochondrial serine protease HtrA2/Omi cleaves RIP1 during apoptosis of Ba/F3 cells induced by growth factor withdrawal (2010) (31)
- Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs (2018) (30)
- Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity (2021) (29)
- Influenza and Memory T Cells: How to Awake the Force (2016) (28)
- Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an Antibody (2015) (28)
- Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: identification of two cleavage sites by microsequencing. (2004) (28)
- Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses (2015) (26)
- An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models (2021) (25)
- Role of IFN-alpha during the acute stage of a swine influenza virus infection. (2010) (25)
- Vaccination with influenza hemagglutinin‐loaded ceramic nanoporous microneedle arrays induces protective immune responses (2019) (25)
- CD8+ T cell immunity against human respiratory syncytial virus. (2014) (24)
- mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice (2020) (24)
- Soluble recombinant influenza vaccines. (2001) (24)
- Metabolic profiling of insect cell lines: Unveiling cell line determinants behind system's productivity (2014) (23)
- Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza (2017) (23)
- Inflammatory monocytes regulate Th1 oriented immunity to CpG adjuvanted protein vaccines through production of IL-12 (2017) (23)
- Vaccines against human respiratory syncytial virus in clinical trials, where are we now? (2019) (22)
- Insight into structural diversity of influenza virus haemagglutinin. (2013) (22)
- The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration (2020) (22)
- The caspase-generated fragments of PKR cooperate to activate full-length PKR and inhibit translation (2007) (21)
- Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections (2018) (21)
- Effect of serial pig passages on the adaptation of an avian H9N2 influenza virus to swine (2017) (21)
- Controlling Influenza by Cytotoxic T-Cells: Calling for Help from Destroyers (2010) (20)
- A GFP Expressing Influenza A Virus to Report In Vivo Tropism and Protection by a Matrix Protein 2 Ectodomain-Specific Monoclonal Antibody (2015) (19)
- Modification of the protein glycosylation pathway in the methylotrophic yeast Pichia pastoris (1998) (19)
- Influenza vaccines to control influenza-associated bacterial infection: where do we stand? (2015) (19)
- Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells (2005) (19)
- Transiently Thermoresponsive Acetal Polymers for Safe and Effective Administration of Amphotericin B as a Vaccine Adjuvant. (2017) (19)
- Reverse engineering synthetic antiviral amyloids (2020) (19)
- New antibody-based prevention and treatment options for influenza. (2019) (19)
- Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective. (2011) (18)
- Delivery of Mixed-Lineage Kinase Domain-Like Protein by Vapor Nanobubble Photoporation Induces Necroptotic-Like Cell Death in Tumor Cells (2019) (18)
- Sequence-dependent Internalization of Aggregating Peptides* (2014) (18)
- Identification of polymorphisms in the ovine Shadow of prion protein (SPRN) gene and assessment of their effect on promoter activity and susceptibility for classical scrapie. (2010) (18)
- GM-CSF treatment prevents respiratory syncytial virus-induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation. (2016) (17)
- Mx1 in Hematopoietic Cells Protects against Thogoto Virus Infection (2019) (16)
- Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice (2019) (16)
- A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody. (1995) (15)
- The C terminus of NS1 protein of influenza A/WSN/1933(H1N1) virus modulates antiviral responses in infected human macrophages and mice. (2015) (15)
- Immuno-modulating properties of saliphenylhalamide, SNS-032, obatoclax, and gemcitabine. (2016) (15)
- Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection (2017) (15)
- Oral delivery of Escherichia coli persistently infected with M2e‐displaying bacteriophages partially protects against influenza A virus (2017) (14)
- Passively transferred M2e‐specific monoclonal antibody reduces influenza A virus transmission in mice (2018) (14)
- Influenza-binding sialylated polymer coated gold nanoparticles prepared via RAFT polymerization and reductive amination. (2016) (14)
- Caspase-mediated cleavage of the U snRNP-associated Sm-F protein during apoptosis (2003) (13)
- Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies (2019) (13)
- Immunogenicity of Live Attenuated B. pertussis BPZE1 Producing the Universal Influenza Vaccine Candidate M2e (2013) (13)
- A reassortant H9N2 influenza virus containing 2009 pandemic H1N1 internal-protein genes acquired enhanced pig-to-pig transmission after serial passages in swine (2017) (13)
- Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein. (2015) (13)
- Apoptotic Pathways and Their Regulation (2005) (12)
- Viral dosing of influenza A infection reveals involvement of RIPK3 and FADD, but not MLKL (2021) (12)
- An Inside Job: Applications of Intracellular Single Domain Antibodies (2020) (12)
- A 20 ( Tnfaip 3 ) Deficiency in Myeloid Cells Protects against Influenza A Virus Infection (2012) (11)
- Insight into Highly Conserved H1 Subtype-Specific Epitopes in Influenza Virus Hemagglutinin (2014) (11)
- Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen. (2015) (11)
- Scop3D: Three‐dimensional visualization of sequence conservation (2015) (10)
- Clonotypic analysis of protective influenza M2e-specific lung resident Th17 memory cells reveals extensive functional diversity (2022) (10)
- Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization (2018) (10)
- A Bcl-2 transgene expressed in hepatocytes does not protect mice from fulminant liver destruction induced by Fas ligand. (2003) (10)
- Caspase-mediated cleavage of the exosome subunit PM/Scl-75 during apoptosis (2007) (10)
- Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface (2019) (9)
- Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection (2019) (9)
- Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ (2018) (9)
- Illumina MiSeq sequencing disfavours a sequence motif in the GFP reporter gene (2016) (9)
- Influenza Neuraminidase Characteristics and Potential as a Vaccine Target (2021) (9)
- Recombinant viruses delivering the necroptosis mediator MLKL induce a potent antitumor immunity in mice (2020) (9)
- Translation inhibition in apoptosis: caspase-dependent PKR activation and eIF2-α phosphorylation: Caspase-dependent PKR activation and eIF2-α phosphorylation (2001) (8)
- Correction: A20 (Tnfaip3) Deficiency in Myeloid Cells Protects against Influenza A Virus Infection (2012) (8)
- Single-domain antibodies make a difference (2021) (8)
- Strategy and Performance Evaluation of Low-Frequency Variant Calling for SARS-CoV-2 Using Targeted Deep Illumina Sequencing (2021) (8)
- The influenza matrix protein 2 as a vaccine target (2008) (8)
- Evaluation of recombinant A/Victoria/3/75 (H3N2) influenza neuraminidase mutants as potential broad-spectrum subunit vaccines against influenza A (1998) (7)
- How RSV Proteins Join Forces to Overcome the Host Innate Immune Response (2022) (7)
- Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice (2016) (7)
- Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant (2020) (6)
- Neutralization of Junín virus by single domain antibodies targeted against the nucleoprotein (2018) (6)
- Identification of peptide domains involved in the subcellular localization of the feline coronavirus 3b protein (2019) (5)
- Therapeutic anti-tumor immunity directed against neo-epitopes by intratumor delivery of mRNA encoding MLKL (2018) (5)
- Whole-genome-based phylogenomic analysis of the Belgian 2016–2017 influenza A(H3N2) outbreak season allows improved surveillance (2021) (5)
- A Vulnerable, Membrane-Proximal Site in Human Respiratory Syncytial Virus F Revealed by a Prefusion-Specific Single-Domain Antibody (2021) (5)
- Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents (2021) (5)
- Chemical-controlled Activation of Antiviral Myxovirus Resistance Protein 1* (2016) (4)
- Cell-Mediated Responses to Human Metapneumovirus Infection (2020) (4)
- Strategy and performance evaluation of low-frequency variant calling for SARS-CoV-2 in wastewater using targeted deep Illumina sequencing (2021) (4)
- Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein (2020) (4)
- Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant. (2020) (3)
- Presenting heterologous epitopes with hepatitis B core-based virus-like particles (2014) (3)
- Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells (2022) (3)
- A two-amino acid mutation in murine IgA enables downstream processing and purification on staphylococcal superantigen-like protein 7. (2019) (3)
- Mx Proteins: Antiviral Gatekeepers That Restrain the Uninvited (2014) (3)
- ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection (2021) (2)
- Vaccine development by recombinant DNA technology. Part I: DNA Vaccines (2008) (2)
- Vaccine development by recombinant DNA technology. Part II: Virus-like Particles (2008) (2)
- One Against All: A Broadly Influenza Neutralizing Man-made Monoclonal Antibody Passes Phase I (2016) (2)
- Cutting Edge Approaches Toward Novel and Cross-Protective Influenza Vaccines (2012) (2)
- TIV Vaccination Modulates Host Responses to Influenza Virus Infection that Correlate with Protection against Bacterial Superinfection (2019) (2)
- In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression (2021) (2)
- Mitochondria: Breathe or die (2005) (2)
- Fas-Induced Necrosis (2006) (1)
- Whole-Genome Sequence Approach and Phylogenomic Stratification Improve the Association Analysis of Mutations With Patient Data in Influenza Surveillance (2022) (1)
- The Use of Proteomics to Identify and Characterize Cell Death Proteins (2005) (1)
- dependent and does not induce inflammatory cytokine production (2003) (1)
- Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase (2022) (1)
- Three-dimensional structure of the extracellular domain of Matrix protein 2 of influenza A virus (2014) (1)
- Single Domain Camelid Antibodies that Neutralize Negative Strand Viruses (2012) (1)
- Author Correction: A reassortant H9N2 influenza virus containing 2009 pandemic H1N1 internal-protein genes acquired enhanced pig-to-pig transmission after serial passages in swine (2018) (1)
- Can antiviral drug-resistant chikungunya viruses be transmitted by mosquitoes ? (2016) (1)
- Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions (2021) (1)
- The hyperinflammatory reactivity of post-asthma alveolar macrophages contributes to RSV-induced asthma exacerbations (HYP7P.269) (2015) (1)
- Role of mitochondrial proteins in apoptosis. (2008) (1)
- Production and Purification of Recombinant Filamentous Bacteriophages Displaying Immunogenic Heterologous Epitopes. (2016) (1)
- An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25 (2022) (1)
- Tailor-made cleavage site attenuates influenza B (2012) (1)
- A general approach to identify low-frequency variants within influenza samples collected during routine surveillance (2022) (0)
- Receptor interacting protein RIP1, a crucial adaptor kinase in necrotic signaling (2004) (0)
- Inflammatory monocytes regulate Th1 oriented immunity to CpG adjuvanted protein vaccines through production of IL-12 (2017) (0)
- Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing (2015) (0)
- MiceEpitope Reduces RSV Replication in 85-93 Respiratory Syncytial Virus (RSV) F Recombinant Influenza Virus Carrying the (2014) (0)
- Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies (2022) (0)
- Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface (2019) (0)
- Development of Digital Droplet PCR Targeting the Influenza H3N2 Oseltamivir-Resistant E119V Mutation and Its Performance through the Use of Reverse Genetics Mutants (2023) (0)
- Towards the use of interleukin-1β as vaccine adjuvant (2019) (0)
- Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes (2018) (0)
- Mediate Protection Receptors and Alveolar Macrophages Matrix Protein 2 of Influenza A: Fc Universal Vaccine Based on Ectodomain of (2010) (0)
- Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza B (2023) (0)
- ID: 208: Comparison of the antiviral activity of Mus spretus Mx1 and Mus musculus A2G Mx1 against influenza A viruses (2015) (0)
- Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase (2022) (0)
- Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs (2018) (0)
- Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike (2023) (0)
- The use of proteomics in the study of cell death (2004) (0)
- Reverse engineering synthetic antiviral amyloids (2020) (0)
- Protection against H5N1 influenza by immunoglobulin single variable domains (2011) (0)
- Cov2MS: an automated matrix-independent assay for mass spectrometric detection and measurement of SARS-CoV-2 nucleocapsid protein in infectious patients (2022) (0)
- Innate imprinting of resident alveolar macrophages in RSV-induced allergic asthma exacerbations (P6003) (2013) (0)
- Infection-permissive immunity provided by NA- and M2e-based vaccines protects against influenza A virus challenge and allows the induction of heterosubtypic immunity during subsequent infections. (VAC5P.1127) (2015) (0)
- IgG3 Snitcher of RSV Infections in the Very Young (2017) (0)
- Protein synthesis during apostosis and necrosis: a comparative study (2003) (0)
- 125 : The Sin3a repressor complex regulates the balance between the activities of different STAT proteins (2013) (0)
- Complex of Influenza M2e and Antibody (2015) (0)
- A novel human Respiratory Syncytial Virus vaccine based on the extracellular domain of the Small Hydrophobic protein (2012) (0)
- Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies (2022) (0)
- Type II autophagic cell death and death-associated protein kinases (2003) (0)
- Chapter Number 1 Single Domain Camelid Antibodies that 2 Neutralize Negative Strand Viruses 3 (2012) (0)
- Nanobody targeting influenza A matrix protein 2 ectodomain (M2e) (2020) (0)
- Differences and similarities in phagocytosis of apoptotic and necrotic cells by macrophages (2002) (0)
- Neutralization of Junín virus by single domain antibodies targeted against the nucleoprotein (2018) (0)
- Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair (2022) (0)
- Cov2MS: An Automated and Quantitative Matrix-Independent Assay for Mass Spectrometric Measurement of SARS-CoV-2 Nucleocapsid Protein (2022) (0)
- KEX2-like processing of glucoamylase-interleukin 6 and cellobiohydrolase-interleukin 6 fusion proteins by Trichoderma reesei (1994) (0)
- Intracellular Delivery of mRNA in Adherent and Suspension Cells by Vapor Nanobubble Photoporation (2020) (0)
- Author Correction: A reassortant H9N2 influenza virus containing 2009 pandemic H1N1 internal-protein genes acquired enhanced pig-to-pig transmission after serial passages in swine (2018) (0)
- Selected talk 2 MCMV exploits the spleen as a transfer hub for systemic dissemination upon oronasal inoculation (2015) (0)
- APOPTOTIC PATHWAYS AND THEIR REGULATION Chapter I (2005) (0)
- P131 STAT transcriptional activity is controlled by regulated deacetylation (2012) (0)
- ANTIBACTERIAL, ANTI-ALPHA GLUCOSIDASE AND ANTIOXIDANT PROPERTIES OF DILLENIA PENTAGYNA ROXB. (DILLENIACEAE) (2013) (0)
- Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences: 356 (1416) (2001) (0)
- Proteomic data and structure analysis combined reveal interplay of structural rigidity and flexibility on selectivity of cysteine cathepsins (2023) (0)
- A reassortant H9N2 influenza virus containing 2009 pandemic H1N1 internal-protein genes acquired enhanced pig-to-pig transmission after serial passages in swine (2017) (0)
- Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice (2019) (0)
- Mitochondrial intermembrane proteins in cell death q (2003) (0)
- Walter Fiers (1931–2019) (2019) (0)
This paper list is powered by the following services:
Other Resources About Xavier Saelens
What Schools Are Affiliated With Xavier Saelens?
Xavier Saelens is affiliated with the following schools:
